Welcome to our dedicated page for Option Care Health news (Ticker: OPCH), a resource for investors and traders seeking the latest updates and insights on Option Care Health stock.
Option Care Health, Inc. (symbol: OPCH) is the largest independent provider of home and alternate site infusion services in the United States. With a dedicated team of over 7,500 members, including more than 4,500 clinicians, the company is at the forefront of delivering compassionate care to patients with acute and chronic conditions across all 50 states.
Formed from the merger of Option Care and BioScrip in August 2019, the company has successfully integrated its operations to create a unified national team. This merger has enabled Option Care Health to leverage its clinical leadership, extensive expertise, and national scale to reimagine the infusion care experience for patients, customers, and employees.
Option Care Health specializes in providing a variety of infusion therapies, including treatments for bleeding disorders, neurological conditions, heart failure, anti-infectives, and chronic inflammatory disorders. The company operates through home and alternate site settings, ensuring that patients receive care in a comfortable and convenient environment.
Recent achievements include strong financial performance, as highlighted in the company's third-quarter 2023 results. The CEO, John C. Rademacher, emphasized the outstanding clinical outcomes and extraordinary patient care that have contributed to these solid financial results. For the full year 2023, the company expects to generate substantial revenues and has provided updated financial guidance, reflecting its robust financial health.
The company's commitment to innovation is evident in its continuous efforts to elevate standards of care. Its clinical leadership and national scale allow Option Care Health to implement cutting-edge solutions that improve patient outcomes, reduce costs, and enhance the overall care experience.
Option Care Health's significant partnerships and collaborations further strengthen its market position. The company recently announced an increase in its share repurchase program authorization from $250 million to $500 million, demonstrating its confidence in its financial stability and future growth prospects.
For more information and the latest updates, please visit Option Care Health's Investor Relations page.
Option Care Health (Nasdaq: OPCH) reported strong financial results for Q1 2021, with net revenue of $759.2 million, an increase of 7.6% from the previous year. Gross profit rose to $165.5 million, representing 21.8% of net revenue. The net loss narrowed to $2.9 million, or $0.02 per share, improving from a loss of $19.9 million in Q1 2020. Adjusted EBITDA surged 30% to $52.2 million. The company also announced the retirement of its second lien debt and an acquisition of chronic therapy assets for $18.5 million.
Option Care Health (NASDAQ: OPCH), the largest independent provider of home and alternate site infusion services in the U.S., will present at the Bank of America 2021 Health Care Conference on May 11, 2021, at 8:45 a.m. EDT. CEO John Rademacher and CFO Mike Shapiro are scheduled to represent the company during this event. With over 5,000 employees, including around 2,900 clinicians, Option Care Health focuses on enhancing care standards for patients with both acute and chronic conditions across all 50 states.
Option Care Health (NASDAQ: OPCH) announced its first-quarter earnings report will be released on May 6, 2021, before market opening. The management team will host a conference call at 8:30 a.m. E.T. to discuss the results. Option Care Health is the largest independent provider of home and alternate site infusion services in the U.S., employing over 5,000 individuals, including about 2,900 clinicians. The company aims to enhance care standards for patients with both acute and chronic conditions across all 50 states.
Option Care Health announced that an affiliate of Madison Dearborn Partners will sell 12,000,000 shares of its common stock at $20.00 per share in an underwritten public offering. This represents approximately 6.7% of shares outstanding, which may increase to 7.7% if the underwriter's option for an additional 1,800,000 shares is exercised. The sale is expected to close on March 17, 2021, with Goldman Sachs acting as the underwriter. Option Care will not receive any proceeds from this offering, and the Selling Stockholder's ownership will decrease from 54.0% to 47.3%.
Option Care Health announced the sale of 12 million shares of its common stock by Madison Dearborn Partners, representing approximately 6.7% of the total shares outstanding. The underwritten public offering includes a 30-day option for the underwriter to purchase an additional 1.8 million shares. After this sale, Madison Dearborn's ownership will decrease from 54% to 47.3%. The company will not receive any proceeds from this offering, and the sole underwriter is Goldman Sachs & Co. LLC.
Option Care Health (Nasdaq: OPCH) reported strong financial results for Q4 and full year 2020. Net revenue for Q4 reached $804.7 million, marking an 11.6% increase year-over-year. Full year net revenue was $3.032 billion, up 31.3%. The company achieved a net income of $17.8 million or $0.10 EPS, compared to a loss in the previous year. Adjusted EBITDA rose 69.5% to $221.7 million. Full year guidance for 2021 predicts revenue between $3.20 billion and $3.25 billion.
Option Care Health announced a public offering of 15,000,000 shares at $18.50 each, up from a previously planned 10,000,000 shares. The underwriter, Goldman Sachs, has a 30-day option to purchase an additional 2,250,000 shares. The offering will close on February 10, 2021. The sale will decrease the Selling Stockholder's interest in the Company from 63.6% to 55.2%. The Company will not receive any proceeds from this offering, which accounts for approximately 8.3% of the outstanding shares, or 9.6% with full exercise of the underwriter's option.
Option Care Health (NASDAQ: OPCH) announced the sale of 10,000,000 shares of its common stock by an affiliate of Madison Dearborn Partners in an underwritten public offering. This sale represents approximately 5.6% of shares outstanding and could increase to 6.4% with an additional 1,500,000 shares option. Post-offering, the Selling Stockholder's ownership will reduce from 63.6% to 58.0%. The offering is managed by Goldman Sachs & Co. LLC, and the Company will not receive any proceeds from the sale.
Option Care Health (NASDAQ: OPCH) announced preliminary financial results for Q4 and the fiscal year ending December 31, 2020. For Q4, net revenue is expected to be between $800 million to $805 million, an 11% growth year-over-year. Net income is projected at $16 million to $18 million, with adjusted EBITDA between $66 million to $68 million, reflecting a 25% to 28% increase. For FY 2020, net revenue is projected at approximately $3.03 billion, but a net loss is anticipated between $7.9 million to $9.9 million.
Option Care Health (NASDAQ: OPCH) has successfully issued $250 million in additional first lien term loans, aimed at extinguishing $246 million of second lien notes. This financing simplifies the company's capital structure and reduces its cash interest burden, as the interest rate on the new loans is set at Libor plus 3.75%, compared to Libor plus 8.75% for the extinguished notes. The new loans have a maturity date set for August 2026 and will reflect in the first quarter 2021 financial results.
FAQ
What is the current stock price of Option Care Health (OPCH)?
What is the market cap of Option Care Health (OPCH)?
What services does Option Care Health provide?
How many states does Option Care Health operate in?
Who are the key team members at Option Care Health?
What recent financial achievements has Option Care Health reported?
What was the impact of the merger between Option Care and BioScrip?
How does Option Care Health ensure quality care?
What is the focus of Option Care Health's innovation?
What is Option Care Health's share repurchase program?
Where can investors find more information about Option Care Health?
How can patients receive care from Option Care Health?
